What specific physiological changes occur in the body at high altitudes that disrupt the stability of Zone 2 heart rates, and how might these changes impact an athletes ability to maintain a consistent power output over the course of a prolonged climb or endurance event.
Would the effects of altitude sickness on Zone 2 heart rate stability be more pronounced in athletes who have a higher aerobic capacity, or would they be more resilient to these effects due to their increased mitochondrial density and capillarization.
Are there any specific training protocols or strategies that can help athletes to mitigate the negative effects of altitude sickness on Zone 2 heart rate stability, such as high-intensity interval training or altitude-specific conditioning exercises.
Can the use of heart rate variability monitoring or other biomarkers provide valuable insights into an athletes susceptibility to altitude sickness and its impact on Zone 2 heart rate stability, or would these metrics be too variable to provide reliable data in this context.
Would the effects of altitude sickness on Zone 2 heart rate stability be more pronounced in athletes who have a higher proportion of slow-twitch muscle fibers, or would these athletes be more resistant to the negative effects of high altitude due to their increased endurance capabilities.